In particular, DLK1 overexpression has been associated with increased aggressiveness and poor outcome in glioblastoma (GBM), hepatocellular carcinoma, ovarian, prostate, and lung cancer.11,47,49,50,90,92,93. The gene discussed is DLK1; the disease is hepatocellular carcinoma.